Treatment of Recalcitrant Neovascular AMD Using Brolocizumab With Immediate T&E

Clinical trial NCT05710471 · COMPLETED

Trial details

NCT number: NCT05710471
Sponsor: The University of Hong Kong
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Age-Related Macular Degeneration

Start date: 2022-07-25
Primary completion: 2023-07-25
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.